Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01312181 · ClinicalTrials.gov registry record · NA
HealthCall:Brief Intervention to Reduce Non-injecting Drug Use in HIV Primary Care Clinics
A NA study, sponsored by Research Foundation for Mental Hygiene.
- Completed
- Registry status
- NA
- Development phase
- 240
- Enrollment target
NCT01312181: Completed NA study, sponsored by Research Foundation for Mental Hygiene.
NCT01312181 is a NA study that has completed, run by Research Foundation for Mental Hygiene. The registered enrollment target is 240 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (83% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01312181, a NA study, has completed, sponsored by Research Foundation for Mental Hygiene.
- COMPLETED
- Registry status
- NA
- Development phase
- 240 participants
- Enrollment target
Study Summary
Among HIV-infected individuals, non-injection drug use (NIDU) is associated with poor HIV medication adherence, greater HIV/AIDS risk behaviors, and increasing non-AIDS mortality. Thus reducing NIDU among HIV infected individuals is critical to their survival and to limiting the spread of HIV. We propose to study the efficacy of a technologically enhanced brief intervention (HealthCall) to reduce NIDU in HIV primary care patients that demands little from busy medical staff and is well accepted by patients. In a 3-arm randomized clinical trial will test the efficacy of (a) Motivational Interviewing (MI)+HealthCall; (b) MI-only; and (c) a control condition (advice + DVD HIV health education) in reducing NIDU.
Primary Outcome
One primary study outcome was frequency of drug use, represented by the total number of days of primary drug used in the prior 30 days (NumDU) as derived from the Time Line Follow Back (TLFB).
Interventions
- BEHAVIORAL Motivational Interviewing (MI)
- BEHAVIORAL HealthCall and Motivational Interviewing
- BEHAVIORAL HIV/AIDS health education
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 240 participants |
| Start Date | 2011-06 |
| Est. Completion | 2016-08 |
| Phase | NA |
What the finished NCT01312181 record still lists
NCT01312181 is an interventional study that assigns participants to a tested intervention. The registered 240 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (83% lower).
The record links to 0 conditions, and to 3 interventions - of which Motivational Interviewing (MI) is the first listed.
NCT01312181 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01312181 about?
NCT01312181 is a clinical study titled "HealthCall:Brief Intervention to Reduce Non-injecting Drug Use in HIV Primary Care Clinics". Among HIV-infected individuals, non-injection drug use (NIDU) is associated with poor HIV medication adherence, greater HIV/AIDS risk behaviors, and increasing non-AIDS mortality. Thus reducing NIDU among HIV infected individuals is critical to their survival and to limiting the spread of HIV. We pr...
What is the current status of trial NCT01312181?
This trial is currently completed. It is a NA study. The enrollment target is 240 participants. The study started on 2011-06. Estimated completion is 2016-08.
What interventions are being tested in trial NCT01312181?
The interventions under investigation include: Motivational Interviewing (MI) (BEHAVIORAL), HealthCall and Motivational Interviewing (BEHAVIORAL), HIV/AIDS health education (BEHAVIORAL).
Who is sponsoring clinical trial NCT01312181?
This trial is sponsored by Research Foundation for Mental Hygiene, which has 27 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01312181's enrollment target sits among peer trials
240 440th of 2000 higher than 1,542 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02855554 · 240 participants · NA
Quantitative Cardiac Parametric Mapping
- NCT03230565 · 240 participants · Phase 4
Continuous Infusions vs Scheduled Bolus Infusions
- NCT03399929 · 240 participants
Traumatic Brain Injury and Stroke Long Term Outcome
- NCT03583710 · 240 participants · Phase 3
Mitotane With or Without Cisplatin and Etoposide After Surgery in Treating Patients With Stage I-III Adrenocortical Cancer With High Risk of Recurrence
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia